LGV portfolio company Craegmoor Healthcare Group has refinanced its whole business securitisation with a £255m bank facility arranged by the Bank of Scotland. As a part of the refinancing, Craegmoor fully redeemed all the outstanding notes of Craegmoor Funding No. 2 Ltd, the securitisation financing vehicle, including an agreed early redemption premium. The signing of the new facility provides Craegmoor with a strong capital base, substantially reduces its ongoing debt service obligations and provides it with the financial and operational flexibility to move to the next stage of its development.
Secondaries activity is recovering from the initial coronavirus-related shock, with good prospects for GP-led secondaries deals
Sale of the drive technology unit saw interest from sponsors including CVC, Triton and Brookfield
AUM bump driven by commitments to CapMan Nordic Real Estate III and CapMan Growth II funds
This round is an extension to an €11m series-B investment raised by the company in July 2019